158 related articles for article (PubMed ID: 38015442)
1. A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina.
Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Nowbar AN; Simader FA; Davies JR; O'Kane PD; Haworth P; Routledge H; Kotecha T; Gamma R; Clesham G; Williams R; Din J; Nijjer SS; Curzen N; Ruparelia N; Sinha M; Dungu JN; Ganesananthan S; Khamis R; Mughal L; Kinnaird T; Petraco R; Spratt JC; Sen S; Sehmi J; Collier DJ; Sohaib A; Keeble TR; Cole GD; Howard JP; Francis DP; Shun-Shin MJ; Al-Lamee RK;
N Engl J Med; 2023 Dec; 389(25):2319-2330. PubMed ID: 38015442
[TBL] [Abstract][Full Text] [Related]
2. A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial.
Nowbar AN; Rajkumar C; Foley M; Ahmed-Jushuf F; Howard JP; Seligman H; Petraco R; Sen S; Nijjer SS; Shun-Shin MJ; Keeble TR; Sohaib A; Collier D; McVeigh P; Harrell FE; Francis DP; Al-Lamee RK
EuroIntervention; 2022 Apr; 17(18):1490-1497. PubMed ID: 35156616
[TBL] [Abstract][Full Text] [Related]
3. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.
Al-Lamee R; Howard JP; Shun-Shin MJ; Thompson D; Dehbi HM; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik IS; Cook C; Ahmad Y; Sharp ASP; Gerber R; Baker C; Kaprielian R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom SA; Davies JE; Francis DP
Circulation; 2018 Oct; 138(17):1780-1792. PubMed ID: 29789302
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
Al-Lamee R; Thompson D; Dehbi HM; Sen S; Tang K; Davies J; Keeble T; Mielewczik M; Kaprielian R; Malik IS; Nijjer SS; Petraco R; Cook C; Ahmad Y; Howard J; Baker C; Sharp A; Gerber R; Talwar S; Assomull R; Mayet J; Wensel R; Collier D; Shun-Shin M; Thom SA; Davies JE; Francis DP;
Lancet; 2018 Jan; 391(10115):31-40. PubMed ID: 29103656
[TBL] [Abstract][Full Text] [Related]
5. Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial.
Foley MJ; Rajkumar CA; Ahmed-Jushuf F; Simader FA; Chotai S; Pathimagaraj RH; Mohsin M; Salih A; Wang D; Dixit P; Davies JR; Keeble TR; Cosgrove C; Spratt JC; O'Kane PD; De Silva R; Hill JM; Nijjer SS; Sen S; Petraco R; Mikhail GW; Khamis R; Kotecha T; Harrell FE; Kellman P; Francis DP; Howard JP; Cole GD; Shun-Shin MJ; Al-Lamee RK
Lancet; 2024 Apr; 403(10436):1543-1553. PubMed ID: 38604209
[TBL] [Abstract][Full Text] [Related]
6. Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease.
Simader FA; Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Chotai S; Bual N; Khokhar A; Gohar A; Lampadakis I; Ganesananthan S; Pathimagaraj RH; Nowbar A; Davies JR; Keeble TR; O'Kane PD; Haworth P; Routledge H; Kotecha T; Spratt JC; Williams R; Nijjer SS; Sen S; Curzen N; Sinha M; Howard JP; Cole G; Harrell FE; Francis DP; Shun-Shin MJ; Al-Lamee RK;
J Am Coll Cardiol; 2024 Jul; 84(1):13-24. PubMed ID: 38759906
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.
Ferrari R; Ford I; Fox K; Challeton JP; Correges A; Tendera M; Widimský P; Danchin N;
Lancet; 2020 Sep; 396(10254):830-838. PubMed ID: 32877651
[TBL] [Abstract][Full Text] [Related]
8. N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention.
Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Simader FA; Mohsin M; Ganesananthan S; Nowbar AN; Chotai S; Sen S; Petraco R; Nijjer SS; Sehmi J; Ruparelia N; Dungu JN; Kabir A; Tang K; Gamma R; Davies JR; Kotecha T; Cole GD; Howard JP; Keeble TR; Clesham G; O'Kane PD; Harrell FE; Francis DP; Shun-Shin MJ; Al-Lamee RK
J Am Coll Cardiol; 2024 Jul; 84(1):1-12. PubMed ID: 38752902
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.
Hennigan B; Berry C; Collison D; Corcoran D; Eteiba H; Good R; McEntegart M; Watkins S; McClure JD; Mangion K; Ford TJ; Petrie MC; Hood S; Rocchiccioli P; Shaukat A; Lindsay M; Oldroyd KG
Heart; 2020 May; 106(10):758-764. PubMed ID: 32114516
[TBL] [Abstract][Full Text] [Related]
10. Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITA.
Al-Lamee RK; Shun-Shin MJ; Howard JP; Nowbar AN; Rajkumar C; Thompson D; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik I; Bual N; Cook C; Ahmad Y; Seligman H; Sharp ASP; Gerber R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom S; Davies JE; Francis DP
Circulation; 2019 Dec; 140(24):1971-1980. PubMed ID: 31707827
[TBL] [Abstract][Full Text] [Related]
11. Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI.
Götberg M; Christiansen EH; Gudmundsdottir IJ; Sandhall L; Danielewicz M; Jakobsen L; Olsson SE; Öhagen P; Olsson H; Omerovic E; Calais F; Lindroos P; Maeng M; Tödt T; Venetsanos D; James SK; Kåregren A; Nilsson M; Carlsson J; Hauer D; Jensen J; Karlsson AC; Panayi G; Erlinge D; Fröbert O;
N Engl J Med; 2017 May; 376(19):1813-1823. PubMed ID: 28317438
[TBL] [Abstract][Full Text] [Related]
12. Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance.
Völz S; Dworeck C; Redfors B; Pétursson P; Angerås O; Gan LM; Götberg M; Sarno G; Venetsanos D; Grimfärd P; Hofmann R; Jensen J; Björklund F; Danielewicz M; Linder R; Råmunddal T; Fröbert O; Witt N; James S; Erlinge D; Omerovic E
J Am Coll Cardiol; 2020 Jun; 75(22):2785-2799. PubMed ID: 32498806
[TBL] [Abstract][Full Text] [Related]
13. Predicting the Benefits of Percutaneous Coronary Intervention on 1-Year Angina and Quality of Life in Stable Ischemic Heart Disease: Risk Models From the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation).
Zhang Z; Jones P; Weintraub WS; Mancini GBJ; Sedlis S; Maron DJ; Teo K; Hartigan P; Kostuk W; Berman D; Boden WE; Spertus JA
Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003971. PubMed ID: 29752388
[TBL] [Abstract][Full Text] [Related]
14. Association Between Physiological Stenosis Severity and Angina-Limited Exercise Time in Patients With Stable Coronary Artery Disease.
Cook CM; Ahmad Y; Howard JP; Shun-Shin MJ; Sethi A; Clesham GJ; Tang KH; Nijjer SS; Kelly PA; Davies JR; Malik IS; Kaprielian R; Mikhail G; Petraco R; Warisawa T; Al-Janabi F; Karamasis GV; Mohdnazri S; Gamma R; de Waard GA; Al-Lamee R; Keeble TR; Mayet J; Sen S; Francis DP; Davies JE
JAMA Cardiol; 2019 Jun; 4(6):569-574. PubMed ID: 31042268
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics.
Ferrari R; Ford I; Fox K; Marzilli M; Tendera M; Widimský P; Challeton JP; Danchin N
Am Heart J; 2019 Apr; 210():98-107. PubMed ID: 30771737
[TBL] [Abstract][Full Text] [Related]
16. Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
Ganesananthan S; Rajkumar CA; Foley M; Thompson D; Nowbar AN; Seligman H; Petraco R; Sen S; Nijjer S; Thom SA; Wensel R; Davies J; Francis D; Shun-Shin M; Howard J; Al-Lamee R
Eur Heart J; 2022 Sep; 43(33):3132-3145. PubMed ID: 35639660
[TBL] [Abstract][Full Text] [Related]
17. Reclassification of Treatment Strategy With Instantaneous Wave-Free Ratio and Fractional Flow Reserve: A Substudy From the iFR-SWEDEHEART Trial.
Andell P; Berntorp K; Christiansen EH; Gudmundsdottir IJ; Sandhall L; Venetsanos D; Erlinge D; Fröbert O; Koul S; Reitan C; Götberg M
JACC Cardiovasc Interv; 2018 Oct; 11(20):2084-2094. PubMed ID: 30336812
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial.
McCreanor V; Nowbar A; Rajkumar C; Barnett AG; Francis D; Graves N; Boden WE; Weintraub WS; Al-Lamee R; Parsonage WA
BMJ Open; 2021 Feb; 11(2):e044054. PubMed ID: 33563623
[TBL] [Abstract][Full Text] [Related]
19. The challenges of a randomised placebo-controlled trial of CTO PCI vs. placebo with optimal medical therapy: The ORBITA-CTO pilot study design and protocol.
Khan S; Fawaz S; Simpson R; Robertson C; Kelly P; Mohdnazri S; Tang K; Cook CM; Gallagher S; O'Kane P; Spratt J; Brilakis ES; Karamasis GV; Al-Lamee R; Keeble TR; Davies JR
Front Cardiovasc Med; 2023; 10():1172763. PubMed ID: 37206100
[TBL] [Abstract][Full Text] [Related]
20. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI.
Davies JE; Sen S; Dehbi HM; Al-Lamee R; Petraco R; Nijjer SS; Bhindi R; Lehman SJ; Walters D; Sapontis J; Janssens L; Vrints CJ; Khashaba A; Laine M; Van Belle E; Krackhardt F; Bojara W; Going O; Härle T; Indolfi C; Niccoli G; Ribichini F; Tanaka N; Yokoi H; Takashima H; Kikuta Y; Erglis A; Vinhas H; Canas Silva P; Baptista SB; Alghamdi A; Hellig F; Koo BK; Nam CW; Shin ES; Doh JH; Brugaletta S; Alegria-Barrero E; Meuwissen M; Piek JJ; van Royen N; Sezer M; Di Mario C; Gerber RT; Malik IS; Sharp ASP; Talwar S; Tang K; Samady H; Altman J; Seto AH; Singh J; Jeremias A; Matsuo H; Kharbanda RK; Patel MR; Serruys P; Escaned J
N Engl J Med; 2017 May; 376(19):1824-1834. PubMed ID: 28317458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
